So FAP has become the target of pulmonary fibrosis diagnosis and therapy, which interests many researchers (Wenlong et al., 2015; Lin et al., 2019; Wu et al., 2020; Bergmann et al., 2021; Rohrich et al., 2022). The gene discussed is FAP; the disease is pulmonary fibrosis.